Flore by Sun Genomics
Flore by Sun Genomics is a San Diego-based precision probiotics company that sequences customer gut microbiomes via shotgun metagenomics and manufactures individualized synbiotic formulations matched to each profile, selling direct-to-consumer and through a licensed-provider clinical platform.
- Company typePrivate
- Founded2018
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Flore by Sun Genomics does
Flore by Sun Genomics is a San Diego-based precision probiotics company that manufactures individualized synbiotic formulations from a customer's own gut microbiome sequencing data. Its core technology stacks shotgun metagenomic DNA sequencing (analyzing 352 markers across 23,000+ microbes per sample) with a proprietary Central Intelligence Engine — a clinical database and formulation algorithm built from 9 years of paired microbiome-sequencing and symptom-resolution records across 40,000+ prior formulations. The engine matches each customer's microbiome profile against this outcome corpus to select 5-7 strains (from a 68-strain library) plus prebiotics (from 40+ candidates) at clinically meaningful CFU dosing, then compounds the formula in-house in San Diego and cold-ships direct to the consumer.
The company operates three brands under one corporate entity: Flore Custom (the core personalized DTC product, priced $297-$1,069 as 3-, 6-, or 12-month supply plans paid upfront), GoodOnes™ (a system-matched catalog sub-brand drawing on the same outcome database without requiring testing), and Flore Clinical (a provider-facing B2B2C portal for licensed clinicians to prescribe personalized formulas and track patient outcomes). A fourth line, Autism Probiotics, targets ASD-specific gut-brain axis needs. Revenue is subscription-style with single upfront payments and add-on revenue from $99 microbiome coaching sessions and $175 mid-cycle reformulations.
The business is privately held, was originally founded as Sun Genomics, was acquired by Flore Inc. in 2024, and has raised approximately $12.2M in disclosed equity funding (largest round: a 2020 Series A of $9.25M led by Pangaea Ventures with Danone Manifesto Ventures, Emerging Technology Partners, Human Longevity, and Nascita Ventures). The company holds HIPAA, SOC 2 Type II, and AES-256 compliance certifications, holds the only peer-reviewed clinical study in personalized probiotics (mSystems, ASM, 2024, co-published with Arizona State University's Britton Lab), and has RCTs (Regular One, Bright One) underway. Customer concentration is low — the base is a long-tail of individual DTC buyers plus an early-stage clinical provider channel.
Flore by Sun Genomics firmographics
Firmographics- Name
- Flore by Sun Genomics
- Legal name
- Sun Genomics, Inc.
- Website
- https://flore.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Flore by Sun Genomics is a San Diego-based precision probiotics company that sequences customer gut microbiomes via shotgun metagenomics and manufactures individualized synbiotic formulations matched to each profile, selling direct-to-consumer and through a licensed-provider clinical platform.
- Ownership category
- akta.pro rank
Flore by Sun Genomics industry classification
Industry- Product category
- Personalized Probiotics
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Food Manufacturing (311), Medical and Diagnostic Laboratories (6215)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI), Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)
Keywords
Where Flore by Sun Genomics is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Flore by Sun Genomics business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Personalized Probiotic Sales (Direct-to-Consumer): Flore sells custom precision synbiotic formulas directly to consumers via its e-commerce storefront (flore.com). Customers purchase a supply plan (3, 6, or 12 months) and receive a personalized probiotic formulated from their microbiome data. Additional revenue comes from add-ons such as mid-cycle reformulation and microbiome coaching sessions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | 3-Month Supply — $99/mo ($297 paid once) |
| Subscription | Multi-year contract | 6-Month Supply — $94/mo ($564 paid once, save 5%) |
| Subscription | Multi-year contract | 12-Month Supply — $89/mo ($1,069 paid once, save 10%) |
| Unit Pricing | Pay-as-you-go | 30-Min Microbiome Coaching Session |
| Unit Pricing | Pay-as-you-go | Mid-Cycle Reformulation |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Flore by Sun Genomics product offering
Product offeringCore offering
Flore by Sun Genomics manufactures and sells personalized precision synbiotic probiotics formulated from individual customer gut microbiome data. Customers either upload results from a microbiome test (NirvanaBiome or any compatible lab) or complete a health profile; the company's Central Intelligence Engine selects 5–7 strains from a library of 68 probiotic strains and 40+ prebiotics and the formula is compounded in-house in San Diego and cold-shipped directly. The company also operates a clinician-facing prescribing platform (Flore Clinical), a targeted GoodOnes™ catalog, and an Autism Probiotics sub-brand, all drawing from the same outcome-driven formulation database.
Product overview
Flore by Sun Genomics operates as a precision probiotic platform centered on personalized formulation. The core offering is Flore Custom, which sequences customer stool DNA via shotgun metagenomics and manufactures individualized probiotic formulas from a library of up to 68 strains plus 40+ prebiotics. Supporting the consumer brand are GoodOnes™ (targeted synbiotic products without testing), Flore Clinical (provider-facing prescription platform), and Autism Probiotics (ASD-specific formulations). The company also offers Microbiome Coaching add-on sessions. All products draw from the same Central Intelligence Engine clinical database built from 9 years of microbiome outcome data across 40,000+ formulations.
Differentiator
Problem solved
Functional benefit
Brands
- GoodOnes: System-matched formulas without microbiome testing - each built from the same outcome database with strains that earned their place by working
- Flore Clinical
- Autism Probiotics
Products and services
- Flore Custom (Personalized Probiotics) Precision synbiotic system that sequences customer stool DNA via shotgun metagenomics and manufactures a custom probiotic formula from a library of up to 68 curated strains plus 40+ prebiotics, selected based on individual microbiome gaps and clinical outcome data. For consumers seeking personalized microbiome-based digestive, gut-brain, metabolic, and immune support.
- Flore Clinical Clinical platform allowing doctors, dietitians, and researchers to order personalized synbiotic formulas for patients and track clinical-grade microbiome outcomes. For licensed healthcare providers.
- The Regular One (GoodOnes™) System-matched synbiotic for bloating and constipation without requiring microbiome testing. 30 capsules delivered as daily gut motility support, formulated from the same outcome database as Flore Custom.
- The Calm One (GoodOnes™) System-matched synbiotic for anxiety and stress relief via gut-brain axis support, formulated from the same outcome database as Flore Custom.
- The Bright One (GoodOnes™) System-matched synbiotic targeting mood through microbiome-mediated neurotransmitter support.
- The Strong One (GoodOnes™) System-matched synbiotic formulated for daily immune defense support.
- The Little One (GoodOnes™) System-matched pediatric synbiotic formulated for developing microbiomes in children.
- Autism Probiotics Probiotic formulations designed for autistic adults and families, aligned with the #ActuallyAutistic community, built from the same microbiome intelligence and outcome database as Flore Custom.
- Microbiome Coaching 30-minute 1:1 consultation with Dr. Marina De León, PhD (Microbiome Health & Nutrition Consultant) for personalized microbiome health guidance. For consumers seeking expert interpretation of their microbiome data.
Quantifiable outcome
- 47.4% symptom resolution in less than 6 months
- +5 more outcomes
Companies that use Flore by Sun Genomics
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Flore by Sun Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Flore by Sun Genomics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- NirvanaBiomecoreNirvanaBiome is Flore's preferred microbiome testing partner. Flore customers receive $10 off NirvanaBiome tests with code FloreNirvana10, and NirvanaBiome results are accepted directly into Flore's portal for personalized formula generation. Flore also accepts microbiome data from any professional sequencing lab, not exclusively NirvanaBiome.
- Arizona State University (ASU) — Britton LabcoreFlore co-published a peer-reviewed pilot open-label study with Arizona State University (ASU Britton Lab), one of the leading microbiome research programs globally. The study (mSystems, ASM, 2024) demonstrated that Flore precision synbiotics increased gut microbiome diversity and improved GI symptoms in autism spectrum disorder. ASU is listed as a lab source from which Flore accepts microbiome sequencing data.
Scale indicators8 records
Recent moves4 records
Expansion highlights6 records
Flore by Sun Genomics competitors and assessment
Company assessmentDirect peers
- Viome Life Sciences: Direct competitor offering personalized nutrition and supplements based on gut microbiome testing. Like Flore, Viome uses DNA sequencing to recommend custom formulations; Viome's broader scope spans food, supplements, and topical products.
- Seed Health: Premium probiotics brand with a science-forward DTC subscription model. Seed sells multi-strain catalog formulas (not personalized) but competes in the same premium probiotic category with strong brand positioning and retail distribution (Sephora).
- ZOE: Personalized nutrition platform using gut microbiome testing, blood fat, and blood sugar analysis to deliver tailored food and supplement recommendations. Direct competitor in personalized microbiome-driven health, with a research-backed subscription model.
- Pendulum Therapeutics: Probiotics company focused on metabolic health (blood sugar, glucose management, Akkermansia muciniphila). Direct competitor in microbiome-driven metabolic interventions, with overlapping GLP-1 adjacency messaging.
- BIOHM: Gut health company offering probiotics and microbiome testing products including sequencing-based personalization. Competes in the same gut health category with a catalog-plus-testing model.
- Ombre (formerly Thryve): Personalized probiotic brand that analyzes gut microbiome to recommend custom strain formulations. Direct competitor using 16S sequencing rather than shotgun metagenomics.
- DayTwo: Personalized nutrition platform based on gut microbiome analysis, originally spun out of the Weizmann Institute. Provides individualized food recommendations and predictive glycemic response — comparable precision-microbiome approach.
Regional players
- Atlas Biomed: UK-based personalized health company offering microbiome and DNA testing with tailored nutrition recommendations. Operates primarily in Europe; comparable precision-microbiome approach with cross-border appeal.
Emerging players
- Carbiotix: Swedish microbiome testing and prebiotic fiber ingredient company. Adjacent in microbiome analytics and gut-health interventions, with a B2B ingredient focus overlapping Flore's microbiome intelligence.
Broad incumbents
- Care/of: Personalized vitamin and supplement subscription service (acquired by Bayer) offering tailored packs based on a health questionnaire. Competes broadly in personalized wellness supplements but without microbiome sequencing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Flore by Sun Genomics social profiles
Digital presenceFlore by Sun Genomics compliance and trust
Trust signalCompliance3 records
Flore by Sun Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Flore by Sun Genomics leadership team
Management profileNumber of profiles
Profiles3 records
Flore by Sun Genomics subsidiaries and ownership
Company hierarchySubsidiaries3 records
Flore by Sun Genomics funding detail
Funding detailFunding overview
Funding rounds11 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Flore by Sun Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Flore by Sun Genomics
What does Flore by Sun Genomics do?
Flore by Sun Genomics manufactures and sells personalized precision synbiotic probiotics formulated from individual customer gut microbiome data. Customers either upload results from a microbiome test (NirvanaBiome or any compatible lab) or complete a health profile; the company's Central Intelligence Engine selects 5–7 strains from a library of 68 probiotic strains and 40+ prebiotics and the formula is compounded in-house in San Diego and cold-shipped directly. The company also operates a clinician-facing prescribing platform (Flore Clinical), a targeted GoodOnes™ catalog, and an Autism Probiotics sub-brand, all drawing from the same outcome-driven formulation database.
Is Flore by Sun Genomics a public or private company?
Flore by Sun Genomics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Flore by Sun Genomics founded?
Flore by Sun Genomics was founded in 2018. It employs 1 to 10 people.
Where is Flore by Sun Genomics based?
Flore by Sun Genomics is headquartered in San Diego, United States, in the North America region.
How does Flore by Sun Genomics make money?
One revenue line is on record: personalized Probiotic Sales (Direct-to-Consumer).
Who are Flore by Sun Genomics's main competitors?
Direct peers on record are Viome Life Sciences, Seed Health, ZOE, Pendulum Therapeutics, BIOHM, Ombre (formerly Thryve) and DayTwo. Atlas Biomed is listed as a regional player. Carbiotix is listed as an emerging player. Care/of is listed as a broad incumbent.
Does Flore by Sun Genomics have an API?
No public API is recorded for Flore by Sun Genomics.
What industry is Flore by Sun Genomics in?
Flore by Sun Genomics's product category is Personalized Probiotics. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of HLAAAFAJ, Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery). Its NAICS code is 325412 and its SIC code is 2833.